Shandong Boyuan Pharmaceutical&Chemical
301617
WUXINSUIZHUANG
835174
Minami Acoustics
301383
Sinotherapeutics Inc.
688247
Hanyu Group Joint-Stock
300403
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -6.75%6.11B | -20.28%6.46B | -39.11%5.49B | -45.87%4.76B | -36.63%6.55B | -20.28%8.1B | -14.80%9.02B | -6.27%8.79B | 6.91%10.34B | 35.66%10.16B |
Transactional financial assets | 22.10%1.22B | 0.00%700M | 630.00%730M | 250.00%700M | --1B | --700M | --100M | --200M | ---- | ---- |
Notes receivable and accounts receivable | -2.39%2.27B | 21.61%2.35B | 29.40%1.97B | 54.40%2.21B | 60.32%2.32B | 17.70%1.93B | -5.39%1.52B | -32.56%1.43B | -38.34%1.45B | -42.74%1.64B |
-Accounts receivable | -2.39%2.27B | 21.61%2.35B | 29.40%1.97B | 54.40%2.21B | 60.32%2.32B | 17.70%1.93B | -5.39%1.52B | -32.56%1.43B | -38.34%1.45B | -42.74%1.64B |
Other receivables (including interest and dividends) | 40.63%27.58M | 45.85%21.22M | 12.93%23.27M | 419.18%170.67M | -47.27%19.61M | -67.24%14.55M | -87.05%20.6M | -81.79%32.87M | -77.58%37.19M | -63.70%44.41M |
-Other receivable | ---- | 45.85%21.22M | ---- | ---- | ---- | -67.24%14.55M | ---- | -81.79%32.87M | ---- | -63.70%44.41M |
Advance payment | 5.52%88.85M | 85.45%118.99M | 124.36%93.22M | 56.89%84.56M | 72.95%84.2M | -6.23%64.16M | -55.61%41.55M | 101.56%53.9M | -21.96%48.69M | 52.63%68.43M |
Inventories | 30.76%1.06B | 29.38%968.34M | 12.30%947.66M | 1.49%889.77M | -29.60%814.3M | -45.35%748.43M | -40.40%843.88M | -36.80%876.73M | -5.12%1.16B | 98.35%1.37B |
Receivable financing | 114.61%429.21K | -34.16%329.21K | 53.78%307.57K | ---- | -90.98%200K | -65.91%500K | -91.74%200K | -94.27%700K | -80.73%2.22M | 83.31%1.47M |
Other current assets | -25.01%46.73M | -50.50%53.94M | -47.19%54.93M | 59.71%117.04M | -19.02%62.31M | -0.26%108.96M | -82.84%104.02M | -78.94%73.28M | -69.56%76.94M | -66.51%109.25M |
Total current assets | -0.27%10.83B | -8.57%10.67B | -20.10%9.31B | -22.07%8.93B | -17.19%10.86B | -12.89%11.67B | -19.49%11.65B | -14.84%11.46B | -4.54%13.11B | 16.08%13.4B |
Non Current assets | ||||||||||
Investment real estate | -7.49%425.04M | -7.93%426.64M | -7.99%430.44M | -3.56%455.11M | 9.86%459.47M | 9.80%463.42M | 9.61%467.83M | 9.60%471.91M | 2.27%418.24M | 3.86%422.04M |
Long-term equity investment | -5.28%182.11M | -6.55%176.78M | -11.23%193.91M | -10.59%191.12M | -9.97%192.25M | -11.12%189.16M | 4.22%218.45M | 3.43%213.76M | -10.09%213.54M | -8.64%212.83M |
Fixed assets | ---- | 3.47%24.3B | ---- | ---- | ---- | -2.91%23.49B | ---- | -6.09%23.43B | ---- | -4.53%24.19B |
Constru in process | ---- | 19.70%2.06B | ---- | ---- | ---- | -9.57%1.72B | ---- | 88.89%2.25B | ---- | -11.07%1.9B |
Construction materials | ---- | -81.04%120.84M | ---- | ---- | ---- | 49.54%637.38M | ---- | 147.53%973.94M | ---- | 56.17%426.21M |
Intangible assets | 6.73%1.65B | 6.86%1.7B | 6.78%1.76B | 6.69%1.81B | -11.58%1.55B | -11.48%1.59B | -11.20%1.65B | -10.95%1.7B | -9.26%1.75B | -8.05%1.8B |
Goodwill | 0.00%98.32M | 0.00%98.32M | 0.00%98.32M | 0.00%98.32M | 0.00%98.32M | 0.00%98.32M | 0.00%98.32M | 0.00%98.32M | 0.00%98.32M | 0.00%98.32M |
Long deferred expense | -26.65%4.14M | -24.98%4.51M | -23.51%4.89M | -22.21%5.26M | -20.01%5.64M | -16.47%6.02M | --6.39M | --6.77M | --7.05M | --7.2M |
Usufruct assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -85.40%1.6M | -75.41%2.98M |
Other non current assets | 79.74%1.05B | 122.58%929.38M | 39.71%488.93M | 259.14%538.93M | 14.02%585.69M | -16.95%417.55M | -59.28%349.97M | -70.09%150.06M | -18.32%513.68M | -47.30%502.78M |
Total non current assets | 4.84%30.07B | 4.22%29.82B | 2.46%29.69B | 2.45%30.01B | -3.02%28.68B | -3.22%28.62B | -2.65%28.98B | -1.31%29.29B | -4.98%29.57B | -5.88%29.57B |
Total assets | 3.44%40.9B | 0.51%40.49B | -4.01%39B | -4.44%38.94B | -7.37%39.54B | -6.24%40.29B | -8.16%40.63B | -5.53%40.75B | -4.84%42.68B | 0.02%42.97B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -24.32%1.96B | 2.92%3.07B | -8.43%2.74B | -41.51%2.21B | -43.89%2.59B | -33.89%2.98B | -25.80%2.99B | 23.36%3.78B | 48.59%4.62B | 134.65%4.51B |
Notes payable and accounts payable | 1.52%3.13B | -0.63%3.16B | -2.08%3.18B | 0.33%3.65B | -17.51%3.08B | -21.46%3.18B | -27.06%3.25B | -14.91%3.64B | -13.79%3.74B | -2.04%4.04B |
-Notes payable | ---- | ---- | -94.50%53.81M | -89.46%128.62M | -55.82%567.97M | -21.48%1.01B | -25.17%977.63M | 20.74%1.22B | 74.65%1.29B | 88.79%1.28B |
-Accounts payable | 24.45%3.13B | 45.42%3.16B | 37.64%3.13B | 45.58%3.52B | 2.57%2.51B | -21.46%2.17B | -27.84%2.27B | -25.93%2.42B | -31.88%2.45B | -19.90%2.76B |
Contract liabilities | 139.31%11.63M | 227.95%21.9M | 60.03%15.97M | -44.26%6.95M | -91.20%4.86M | -95.76%6.68M | -96.10%9.98M | -95.74%12.47M | 101.33%55.22M | 5,278.30%157.68M |
Advance receipts | 45.77%4.34M | 35.32%8.36M | 12.13%2.45M | 22.54%2.03M | -13.35%2.98M | -17.63%6.18M | 11.29%2.19M | -14.54%1.65M | 41.09%3.44M | 226.04%7.5M |
Salaries payable | 30.76%57.76M | 71.23%74.19M | 85.38%79.87M | 24.26%128.7M | -4.83%44.17M | -8.89%43.33M | -14.49%43.09M | -6.84%103.57M | -21.35%46.41M | -26.66%47.56M |
Taxs payable | 38.48%29.53M | 43.39%31.47M | 188.10%55.72M | 0.37%22.79M | -5.64%21.33M | -3.08%21.95M | -7.79%19.34M | -31.97%22.71M | -82.25%22.6M | -93.10%22.65M |
Other payable (including interest and dividends) | -16.69%73.3M | -12.40%90.98M | -4.13%101.45M | 14.85%94.68M | -75.56%87.98M | -62.05%103.86M | -87.46%105.82M | -90.97%82.44M | -72.39%359.94M | -76.57%273.68M |
-Dividend payable | 0.00%1.95M | 0.00%1.95M | 0.00%1.95M | 0.00%1.95M | 0.00%1.95M | 0.00%1.95M | 0.00%1.95M | 0.00%1.95M | 0.00%1.95M | 0.00%1.95M |
-Other payable | ---- | -12.64%89.03M | ---- | ---- | ---- | -62.50%101.91M | ---- | -91.16%80.49M | ---- | -76.70%271.73M |
Non current liabilities due within one year | 32.47%4.2B | 80.84%5.05B | 49.68%4.45B | 17.24%3.62B | 7.06%3.17B | 2.27%2.79B | 7.48%2.97B | 17.33%3.08B | 14.32%2.96B | 3.00%2.73B |
Other current liabilities | 125.70%1.11M | 178.82%2.09M | 62.60%1.64M | -60.07%518.21K | -75.78%493.97K | -25.29%749.23K | -83.35%1.01M | -74.26%1.3M | -43.08%2.04M | 143.77%1M |
Total current liabilities | 5.13%9.47B | 25.94%11.5B | 13.10%10.63B | -9.27%9.74B | -23.72%9.01B | -22.57%9.13B | -24.43%9.4B | -5.29%10.73B | 2.16%11.81B | 14.89%11.8B |
Current liabilities | ||||||||||
Long term loan | -25.79%7.34B | -35.61%7.13B | -37.12%7.12B | -14.49%8.24B | -0.60%9.89B | 19.25%11.07B | 19.02%11.32B | 9.77%9.64B | 5.81%9.95B | -1.36%9.29B |
Long term salaries pay | -47.16%1.24M | -47.16%1.24M | -47.16%1.24M | -47.16%1.24M | -42.78%2.34M | -42.78%2.34M | -43.14%2.34M | -42.78%2.34M | -33.33%4.09M | -33.33%4.09M |
Estimate liabilities | 306.34%12M | 269.73%11.47M | 43.79%11.08M | 35.50%10.44M | 461.98%2.95M | -4.11%3.1M | 134.68%7.7M | 134.38%7.7M | -88.34%525.47K | -29.77%3.24M |
Deferred tax liabilities | -16.15%10.75M | -24.22%9.72M | -16.15%10.75M | -16.15%10.75M | -13.90%12.82M | -13.90%12.82M | -13.90%12.82M | -13.90%12.82M | -12.21%14.89M | -12.21%14.89M |
Long term deferred income | -0.68%305.21M | 9.42%359.95M | 11.32%386.61M | 4.31%380.36M | -13.12%307.3M | -1.55%328.96M | 2.55%347.3M | 5.17%364.65M | -5.50%353.69M | -11.79%334.14M |
Other non current liabilities | 886.41%2.07B | -47.62%110M | -47.62%110M | -47.62%110M | 0.00%210M | 0.00%210M | 0.00%210M | 0.00%210M | 0.00%210M | 0.00%210M |
Total non current liabilities | -6.58%9.74B | -34.46%7.62B | -35.81%7.64B | -14.47%8.75B | -1.02%10.43B | 18.05%11.63B | 18.04%11.9B | 9.36%10.23B | 5.05%10.54B | -1.89%9.85B |
Total liabilities | -1.15%19.21B | -7.89%19.13B | -14.23%18.27B | -11.81%18.49B | -13.01%19.44B | -4.09%20.76B | -5.42%21.3B | 1.34%20.96B | 3.51%22.35B | 6.59%21.65B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%3.59B | 0.00%3.59B | 0.00%3.59B | 0.00%3.59B | 0.00%3.59B | 0.00%3.59B | 0.00%3.59B | 0.00%3.59B | 0.00%3.59B | 0.00%3.59B |
Capital reserve funds | 0.00%20.44B | 0.00%20.44B | -0.04%20.44B | -0.04%20.44B | -0.00%20.44B | -0.03%20.44B | -0.11%20.45B | -0.14%20.45B | -0.29%20.44B | -0.26%20.45B |
Surplus reserve funds | 0.00%230.14M | 0.00%230.14M | 0.00%230.14M | 0.00%230.14M | 0.00%230.14M | 0.00%230.14M | 0.00%230.14M | 0.00%230.14M | 0.00%230.14M | 0.00%230.14M |
Retained profit | 36.53%-2.75B | 37.59%-3.07B | 27.42%-3.7B | 14.24%-3.98B | -6.03%-4.34B | -57.64%-4.91B | -88.05%-5.1B | -134.43%-4.64B | -249.06%-4.09B | -74.02%-3.12B |
Shareholders equity without minority interests | 7.95%21.51B | 9.55%21.19B | 7.26%20.55B | 3.33%20.28B | -1.23%19.92B | -8.53%19.35B | -11.18%19.16B | -12.06%19.62B | -12.87%20.17B | -6.12%21.15B |
Minority interests | -1.19%175.35M | -0.70%173.91M | 7.14%177.86M | 6.80%178.33M | 5.09%177.47M | 4.91%175.13M | 15.16%166M | 21.53%166.97M | 40.80%168.87M | 42.51%166.93M |
Total shareholder equity | 7.87%21.68B | 9.45%21.37B | 7.26%20.73B | 3.36%20.46B | -1.17%20.1B | -8.42%19.52B | -11.00%19.33B | -11.86%19.79B | -12.59%20.34B | -5.87%21.32B |
Total liabilityies and equity | 3.44%40.9B | 0.51%40.49B | -4.01%39B | -4.44%38.94B | -7.37%39.54B | -6.24%40.29B | -8.16%40.63B | -5.53%40.75B | -4.84%42.68B | 0.02%42.97B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.